Biological and clinical features of patients from the Ma-Spore ALL 2003 trial genotyped for the BIM polymorphism.
收藏数据链接：
官方服务：
资源简介：
Incidence of the BIM polymorphism is 50 out of 411 patients, or 12.2%. Abbreviations: Ma-Spore, Malaysia- Singapore; MRD, minimal residual disease; NCI, National Cancer Institute; PCR, polymerase chain reaction; CCR, continuous complete remission.∧indicates that data was unavailable for some patients.
创建时间：
2015-12-02
